Preventative Medicine for Biotech Companies: Lessons from Life Sciences Litigation

Preventative Medicine for Biotech Companies

WSGR Events

Wednesday, September 18, 2019

Past Event

Wilson Sonsini Goodrich & Rosati
28 State Street, 37th Floor
Boston, Massachusetts
(617) 598-7800

Life sciences companies, with high-stakes clinical trials and FDA applications are increasingly targets of shareholder plaintiffs' lawyers. Unfavorable trial results and adverse FDA decisions often lead to class action securities lawsuits. This presentation provides practical tips so companies and their officers and directors can mitigate the risk of securities litigation by implementing prudent disclosure practices drawn from the rulings in recent securities class action decisions.

Presented with our friends from Woodruff Sawyer.

Contacts

Juliana Campbell

jcampbell@wsgr.com

Presenters

Nicki Locker

Partner

Palo Alto

Nicki represents clients in securities and commercial litigation and investigations.

Decades of securities litigation expertise

View Profile

Leading securities litigation attorney and a "first-rate lawyer" - Chambers

Sean Coady

Senior Vice President, Woodruff Sawyer

Sean serves as Practice Leader of Woodruff Sawyer New England office, and is a driving force in business development initiatives for the region. He is an expert in executive liability and risk management—specifically D&O liability and M&A insurance. He has authored several articles on D&O liability and M&A-related products and has structured financial risk solutions for hundreds of companies. His success representing clients as an insurance broker is the result of his ability to maximize his relationships and his problem-solving skills established during his years as an attorney.

An expert in executive liability and risk management